Methodist Journal

FEATURED GUEST EDITOR

ISSUE INTRO

The Burgeoning Field of Cardio-Oncology

See More
RECOGNITIONS

Barry H. Trachtenberg Leads Issue on Cardio-Oncology

See More

REVIEW ARTICLES See More

Heart Failure in Relation to Anthracyclines and Other Chemotherapies

Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies

The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity

Cardiovascular Toxicities of Radiation Therapy

Electrophysiologic Complications in Cancer Patients

Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?

Future Directions in Cardio-Oncology

CASE REPORTS See More

A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery

Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis

Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve

Uneventful Follow-Up 2 Years after Endovascular Treatment of a High Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

Do Not Pass Flow: Microvascular Obstruction on Cardiac Magnetic Resonance After Reinfarction Following Primary Percutaneous Coronary Intervention

CLINICAL PERSPECTIVES See More

EXCERPTA

Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg

POINTS TO REMEMBER

Onconephrology: An Evolving Field

POINTS TO REMEMBER

Herbal Nephropathy

EXCERPTA

Rolling the Dice on Red Yeast Rice

EDITORIALS

Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”

Vol 14, Issue 1 (2018)

Article Full Text

RECOGNITIONS

Guest Editor Neal Kleiman Leads Issue on the Current Status of Stents

Jump to:
Article Citation:

Guest Editor Neal Kleiman Leads Issue on the Current Status of Stents. Methodist DeBakey Cardiovasc J. 2018;14(1):4.

doi: 10.14797/mdcj-14-1-4

Neal S. Kleiman, M.D.

The editors of the Methodist DeBakey Cardiovascular Journal extend their deepest gratitude to Neal S. Kleiman, M.D., for his leadership in this special issue on the current status of stents. Dr. Kleiman is the medical director of the cardiac catheterization laboratories and program director of the Interventional Cardiology Fellowship at the Houston Methodist DeBakey Heart & Vascular Center at Houston Methodist Hospital. He is also a professor of cardiology for the Houston Methodist Institute for Academic Medicine and Weill Cornell Medical College.

Dr. Kleiman launched his career in Houston shortly after graduating from Columbia University College of Physicians and Surgeons, completing his internship, residency, and cardiology fellowship at Baylor College of Medicine. He joined the Houston Methodist faculty in 2005.

A prolific researcher, Dr. Kleiman has been the principal or collaborating investigator in more than 100 studies and multicenter trials examining arterial thrombosis, clotting, and percutaneous interventions. His laboratory is nationally recognized as a select site for platelet research where Dr. Kleiman leads studies on the effects of antiplatelet therapy in angioplasty procedures for coronary artery disease. Moreover, Dr. Kleiman has published more than 400 peer-reviewed manuscripts, book chapters, and abstracts in publications including the Journal of the American College of Cardiology, Annals of Thoracic Surgery, Circulation, and the European Heart Journal. He is a valued member of our editorial board, along with those of the Journal of Interventional Cardiology, Circulation, the American Heart Journal, and the Journal of Thrombosis and Thrombolysis.

Dr. Kleiman is active in several professional organizations, including the American Heart Association Council on Clinical Cardiology and Council on Thrombosis, and he is a fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

Add Comments

Please login to dialogue with author.

Comments